Cargando…

Serine protease inhibitors could be of benefit in the treatment of COVID-19 disease

Detalles Bibliográficos
Autor principal:	Okeahialam, Basil N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283214/ https://www.ncbi.nlm.nih.gov/pubmed/34345429 http://dx.doi.org/10.1177/20499361211032048

Ejemplares similares

Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?
por: Bittmann, Stefan, et al.
Publicado: (2020)

Economic benefit of back titration in the treatment of hypertension in Jos, Nigeria
por: Okeahialam, Basil N, et al.
Publicado: (2017)

Docking study of transmembrane serine protease type 2 inhibitors for the treatment of COVID-19
por: Solanki, Naishadh
Publicado: (2022)

The role of Serine Proteases and Serine Protease Inhibitors in the migration of Gonadotropin-Releasing Hormone neurons
por: Drapkin, Paola T, et al.
Publicado: (2002)

Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding ‘risks and benefits of bisphosphonates’
por: Kyrgidis, A, et al.
Publicado: (2009)

Could KL-6 levels in COVID-19 help to predict lung disease?
por: Frix, AN, et al.
Publicado: (2020)

Could patients benefit from whole-brain radiotherapy with unilateral hippocampus sparing?
por: Sapienza, Lucas Gomes, et al.
Publicado: (2021)

Could the COVID-19 pandemic aggravate antimicrobial resistance?
por: Rossato, Luana, et al.
Publicado: (2020)

Immunotherapies for COVID-19: Restoring the immunity could be the priority
por: Allaouchiche, Bernard
Publicado: (2020)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Diarylethene‐Based Photoswitchable Inhibitors of Serine Proteases
por: Babii, Oleg, et al.
Publicado: (2021)

Editorial: Serine protease inhibitors and their therapeutic applications
por: Crocetti, Letizia, et al.
Publicado: (2022)

Hindrance of the Proteolytic Activity of Neutrophil-Derived Serine Proteases by Serine Protease Inhibitors as a Management of Cardiovascular Diseases and Chronic Inflammation
por: Burster, Timo, et al.
Publicado: (2021)

The Multiple Effects of SGLT2 Inhibitors Suggest Potential Benefit in COVID-19 Patients
por: Soni, Shubham, et al.
Publicado: (2020)

Anti-inflammatory substances from onions could be an option for treatment of COVID-19—a hypothesis
por: Dorsch, W., et al.
Publicado: (2020)

Periodontal pocket and COVID-19: Could there be a possible link?
por: Elisetti, Nirupa
Publicado: (2021)

COVID-19 patients could be at high risk for dry socket
por: Shetty, Lakshmi, et al.
Publicado: (2021)

Renal failure in COVID-19 ARDS: Could it be partially avoided?
por: Zakynthinos, George E., et al.
Publicado: (2021)

Could diet and exercise reduce risk of COVID-19 syndemic?
por: Chesnut, Walter M., et al.
Publicado: (2021)

siRNA could be a potential therapy for COVID-19
por: Ghosh, Sanhita, et al.
Publicado: (2020)

Could Curcumin Modified Silver Nanoparticles Treat COVID-19?
por: Law, Siukan, et al.
Publicado: (2022)

Could immune activation cause pancreatitis in COVID-19 patients?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2022)

LAMP Assay: Could it be a Boon for the Molecular Diagnosis of COVID-19?
por: Buella Parivallal, P., et al.
Publicado: (2020)

Transparency and information sharing could help abate the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Could nucleocapsid be a next-generation COVID-19 vaccine candidate?
por: Saldivar-Espinoza, Bryan, et al.
Publicado: (2022)

Lupus anticoagulant hypoprothrombinemia syndrome - could it be a sequelae of COVID-19?
por: Stjepovic, Nusa Matijasic, et al.
Publicado: (2023)

Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis
por: Inman, Robert D, et al.
Publicado: (2012)

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
por: Klement-Frutos, Elise, et al.
Publicado: (2021)

Postpartum depression amidst COVID-19 pandemic: What further could be done?
por: Issac, Alwin, et al.
Publicado: (2021)

Could a mannequin simplify rhinopharyngeal swab collection in COVID 19 patients?
por: Boscolo Nata, Francesca, et al.
Publicado: (2020)

Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection?
por: Casale, Manuele, et al.
Publicado: (2020)

Could COVID-19 represent a negative prognostic factor in patients with stroke?
por: Siniscalchi, Antonio, et al.
Publicado: (2020)

Could SARS-CoV-2 or COVID-19 Be a Biological Weapon?
por: DEHGHANI, Arezoo, et al.
Publicado: (2020)

Self-Medication in Peru During the COVID-19 Pandemic: How Harmless It Could Be?
por: Benites-Meza, Jerry K., et al.
Publicado: (2022)

Could symptom overlap of COVID-19 and Guillain–Barré syndrome mask an epidemiological association?
por: Svačina, Martin K. R., et al.
Publicado: (2021)

Persisting on Readability Could Provoke the Risk of Misinformation: A COVID-19 Pandemic Concern
por: Hosseini, Mohammad-Salar, et al.
Publicado: (2021)

Reply to “Could a mannequin simplify rhinopharyngeal swab collection in COVID 19 patients?”
por: Tagliabue, Marta, et al.
Publicado: (2020)

Healthcare worker acute respiratory illness cluster in 2020: Could it be from COVID-19?
por: Kyaw, Win Mar, et al.
Publicado: (2020)

Could Faecalibacterium prausnitzii Amount in the Gut Microbiota Be Used to Monitor the COVID-19 Severity?
por: Demirci, Mehmet
Publicado: (2022)

Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
por: Oronsky, Bryan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tq8l1chutjtjpi1ru94shd991j